When was Integer’s initial public offering (IPO)?

Integer Holdings Corporation (“The Company") made an initial public offering of common stock in 2000 under the name Wilson Greatbatch Technologies (WGT). In 2005 WGT became Greatbatch, Inc, trading under the ticker symbol GB. In 2016, following the combination and Greatbatch, Inc. and Lake Region Medical, the Company was renamed Integer Holdings Corporation and began trading under the ticker symbol ITGR.

On what exchange does Integer trade and what is the stock symbol (ticker)?

Shares of Integer common stock trade on the New York Stock Exchange (NYSE) under the ticker symbol ITGR.

How do I buy Integer stock? Can I purchase Integer stock direct from the company?

Integer is a publicly traded company traded on the New York Stock Exchange (NYSE) under the ticker symbol ITGR. In order to purchase shares of Integer stock, you will need to contact a stock broker, it is not possible to purchase Integer stock directly from the company.

What does Integer do?

Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular and portable medical markets. The company provides innovative, high-quality technologies and manufacturing to Medical Device OEM’s to enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. Greatbatch Medical®, Lake Region Medical® and Electrochem® comprise the company’s brands.

What does Integer sell?

Integer serves the medical device industry focusing on the following lines of high-quality products:

Cardiac Rhythm Management (CRM) & Neuromodulation – Within this product-line Integer offers a comprehensive collection of technologies and capabilities. Integer’s complete spectrum of design, development, and manufacturing expertise provides customers with a superior quality solution in an efficient, cost-effective, and consistent manner.

Cardiac and neuromodulation products include batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, implantable stimulation leads and enclosures used in Implantable Medical Devices (“IMD”). Additionally, we offer value-added assembly for these IMDs. An IMD is an instrument that is surgically inserted into the body to provide diagnosis and/or therapy. One sector of the IMD market is cardiac, which is comprising devices such as implantable pacemakers, implantable cardioverter defibrillators (“ICD”), cardiac resynchronization therapy (“CRT”) devices, cardiac resynchronization therapy with backup defibrillation devices (“CRT-D”), insertable cardiac monitors (“ICM”), and ventricular assist devices. Another sector of the IMD market is neuromodulation, comprised of pacemaker-type devices that stimulate nerves for the treatment of various conditions. Beyond established therapies for pain control, incontinence, movement disorders (Parkinson’s disease, essential tremor and dystonia) and epilepsy, nerve stimulation for the treatment of other disabilities such as sleep apnea, heart failure, migraines, obesity and depression has shown promising results.

The following are the main categories of battery-powered IMDs and the principal illness or symptoms treated by each device:

Device Principal Illness or Symptom
Pacemakers Abnormally slow heartbeat (Bradycardia)
ICDs Rapid and irregular heartbeat (Tachycardia)
CRT / CRT-Ds Congestive heart failure
ICMs Unexplained fainting or risk of cardiac arrhythmias
Neurostimulators Chronic pain, incontinence, movement disorders, epilepsy, obesity, or depression
Cochlear hearing devices Hearing loss

IMD systems generally include an IPG and one or more stimulation leads. An IPG is a battery powered device that produces electrical pulses. A lead then carries this electrical pulse from the IPG to the heart, spinal cord or other location in the body. Our portfolio of proprietary technologies, products, and capabilities has been built to provide our cardiac and neuromodulation customers with a single source for the vast majority of the components and subassemblies required to manufacture an IPG or lead, including complete lead systems. Our investments in research and development have generated proprietary products such as the QHR ® , QMR ® , and QCAPS TM primary battery and capacitor lines, which have enabled our OEM partners to make improvements in their system offerings in terms of device reliability, size, longevity and power. Our Xcellion TM line of Lithium-Ion rechargeable batteries leverages decades of implantable battery research, development and manufacturing expertise. This line of battery cells includes the optional CoreGuard TM feature, which enables batteries to discharge to zero volts without performance degradation.

The following are the principal products and services offered by our Cardiac & Neuromodulation product line:

  • Cardiac Rhythm Management - provides a broad range of products and services to enable next generation CRM medical devices to address heart disease and heart rhythm disorders through such systems as: pacemakers, implantable cardiac defibrillators, cardiac resynchronization therapy devices, implantable cardiac monitors and other novel implantable devices. Integer’s battery and capacitor technologies provide a reliable and safe power source for our customer’s CRM system, based on decades of research, development and manufacturing experience. As a leading supplier of low-polarization specialty-coated electrodes and lead components, Integer provides a full range of therapy delivery development and manufacturing solutions.
  • Neuromodulation – provide a wide range of products and services for our customers’ next generation neuromodulation medical devices. Examples include implantable medical devices that address chronic pain, hearing loss, incontinence, movement disorders, psychiatric disorders, and sleep disorders.

We help our customers develop and manufacture unique neuromodulation solutions, including IPGs, programmer systems, battery chargers, and patient controllers. We offer a full range of therapy delivery development & manufacturing solutions for low-polarization specialty-coated electrodes, lead components and fully finished lead systems.

Cardio & Vascular (C&V)– Offers a full range of products and services from Integer’s global facilities for the development of diagnostic and interventional cardiac and endovascular devices. Integer’s comprehensive design and development services produce components, subassemblies, and finished devices for a wide range of cardiac and endovascular procedures. Following are the principal products and services offered by our C&V product-line:

  • Cardiovascular and structural heart products - products used for vascular, cardiac surgery and structural heart disease. Within this product line, Integer produces guidewire and catheter components, subassemblies and completed devices for cardiovascular, cardiac surgery and structural heart disease applications. For vascular procedures, product applications include introducers, steerable sheaths, guidewires, guide catheters, microcatheters, ultrasound catheters, and delivery systems, balloon expandable delivery systems, stents, atherectomy devices, embolic protection devices, catheter design and assembly, sterile packaging, catheter shafts, radiopaque marker bands, molded hubs, fabricated hypotube assembly, and wire stent frames. For cardiac surgery and structural heart disease procedures, product applications are comprised of access and delivery systems for patient foramen ovale closure devices, vessel harvesting systems, beating heart surgery systems, transcatheter heart valves, heart valves and leaflets, and anastomosis devices.
  • Peripheral Vascular, Neurovascular, Urology and Oncology - products primarily focused on the design and manufacturing of devices used during the treatment of peripheral arterial disease, peripheral transcatheter embolization and occlusion, aortic aneurysm repair, arteriovenous malformations and endoscopic retrograde cholangiopancreatography. Within this product line, we design and manufacture guidewire and catheter components, subassemblies and completed devices for the various applications.
    The primary neurovascular applications for these products are cerebrovascular aneurysms, while the urology and oncology applications are stone retrieval, thermal tumor ablation, transarterial chemoembolization and radio frequency probes. Our products within this area include peripheral vascular and urology guidewires, neurovascular and oncology micro-guidewires, angiographic and diagnostic guidewires, guiding catheters, support and crossing catheters, embolic protection devices, micro-catheters, and delivery systems.
  • Electrophysiology, Infusion Therapy & Hemodialysis - products include devices that are used in the electrophysiology ablation catheter and cardiac rhythm systems. Within this product line, we produce guidewire and catheter components, subassemblies and completed devices for the various electrophysiology applications, as well as components and assemblies for cardiac and neurostimulation leads and implantable pulse generators (“IPG”).
    Electrophysiology atrial fibrillation ablation catheters, which deliver therapy to the heart and eliminate tissue paths for irregular electrical impulses, and electrophysiology catheters, which diagnose irregular electrical impulses in the heart’s electrical system, are the focal points of our electrophysiology offering. For stimulation therapy applications, cardiac rhythm management (“CRM”) devices, such as pacemakers, implantable cardioverter defibrillator, cardiac leads and neurostimulation devices for spinal cord and deep brain stimulation, are the primary applications of focus.

Power Solutions (AS&O) – Offers a broad range of products and services across the many businesses it serves. In partnership with customers, AS&O offers advanced development, engineering and program management, which provides Integer with an in-depth understanding of our customers’ market drivers and end-user needs. Following is more information about the principal products and services offered by Integer’s AS&O product line:

  • Power Solutions - offerings include state of the art customized rechargeable batteries and chargers, non-rechargeable batteries and wireless charging systems. Integer designs and develops basic and “smart” chargers and docking stations of varying complexities to safely and reliably maximize the efficiency of the rechargeable batteries. Integer develops batteries, and the attendant chargers, for patient monitoring, portable defibrillators, and portable ultrasound, X-Ray machines, hearing devices and other devices. Integer collaborates with customers on product development opportunities incorporating our power solutions into Class 1, 2 or 3 medical devices.

Electrochem – Integer’s non-medical power solutions enable the success and advancement of customers’ critical non-medical applications. Whether custom battery packs are used to monitor potential environmental catastrophes, to support troops on the battle field or to explore geologic formations below the earth’s surface, one thing is constant - failure is not an option.

Electrochem provides customized battery power and management systems, charging and docking stations, and power supplies to markets where safety, reliability, quality and durability are critical. We design customized primary (non-rechargeable) and secondary (rechargeable) battery solutions, which are used in the energy, military and environmental markets.

Electrochem’s primary lithium power solutions, which include high, moderate and low rate non-rechargeable cell solutions, are utilized in extreme conditions and can withstand exceptionally high and low temperatures, and high shock and vibration. Electrochem’s product designs incorporate protective circuitry, glass-to-metal hermetic seals, fuses and diodes to help ensure safe, durable and reliable power as devices are subjected to these harsh conditions. Our primary batteries are often used in remote and demanding environments, including down hole drilling tools, military devices, and oceanographic survey vessels buoys.

In addition to primary power solutions, Electrochem offers customized secondary or rechargeable battery packs, in a diverse range of chemistries for critical applications requiring rechargeable solutions. Rechargeable chemistries include lithium ion, lithium ion polymer, nickel metal hydride, nickel cadmium, lithium iron phosphate and sealed lead acid. Electrochem’s rechargeable battery packs include advanced electronics, smart charging and battery management systems and are used in critical military and industrial applications.

Where is Integer headquartered?

Integer’s corporate headquarters are located in Plano, TX, USA. The Company has administrative, manufacturing, and R&D locations globally including in Ireland, Israel, Malaysia, Mexico, Switzerland, the United States, and Uruguay.

How many employees work at Integer?

Integer is a global company with employees located all over the world. The Company reports the total number of employees on an annual basis in its Form 10-K filings. Please find more information about Integer’s global presence here: https://integer.net/our-locations/

How many shares of Integer stock are outstanding?

The number of outstanding shares of Integer common stock fluctuates primarily due to employee equity grants and periodically, as a result of other company activities. The number of outstanding shares is updated on a quarterly basis and can be found in our 10-Q and 10-K filings here .

When is Integer’s year-end?

Integer utilizes a fiscal year ending annually on December 31.

How do I listen to Integer’s quarterly earnings conference call?

Before each earnings call, Integer issues a press release with information regarding how to access the quarterly earnings conference call via phone or webcast. Additionally, earnings conference call replays are accessible for a period of time at https://investor.integer.net

Where can I find archived information for Integer’s quarterly earnings?

All information regarding Integer’s quarterly earnings can be found in the Investor Relations section of the corporate website: here.

Where can I find Integer’s Securities and Exchange Commission (SEC) filings?

All information regarding Integer’s quarterly earnings can be found in the Investor Relations section of the corporate website: here.

Are Integer’s annual reports and proxy statements available online?

Yes. Integer’s annual reports and proxy statements can be found in the Investor Relations section of the corporate website: here.

How can I get a hard copy of Integer’s annual report?

Our annual report can be found in the Investor Relations section of the corporate website to annual reports, where we encourage you to download or print a PDF copy. If you still desire a hard copy, you can submit an information request here.

Who are Integer’s independent auditors?

Deloitte & Touche LLP

Who is Integer’s transfer agent and how do I contact them?

Integer’s transfer agent is Computershare. You can contact them directly via the following:

Computershare Shareholder Services
P.O. Box 30170
College Station, TX 77842-3170

Within the US, please call toll free 1-877-832-7265
If calling from all other countries, please call 1-201-680-6578

Who is on Integer’s Board of Directors?

Information regarding Integer’s Board of Directors can be found in the Investor Relations section of the corporate website: here.

Who should I contact if I am a member of the media?

Members of the media should contact Integer’s public relations team via email at kelly.butler@integer.net.

Who do I contact if I have more questions or want additional information?

Please submit an information request here or contact Investor Relations directly via email at IR@integer.net.


Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

By clicking “Accept” you acknowledge and agree that neither ITGR nor third party provider Virtua Research, Inc. (“Virtua) is responsible, or accepts or assumes any responsibility or liability whatsoever for, the content, the data or the technical operation of the Linked Site. Further, by entering the External Site, you also acknowledge and agree that you completely and irrevocably waive any and all rights and claims against ITGR and Virtua and further acknowledge and agree that in no event shall ITGR or Virtua, its officers, employees, directors and agents be liable for any (i) indirect, consequential, incidental, special, compensatory or punitive damages, (ii) damages for loss of income, loss of business profits, business interruption, loss of data or business information, loss of or damage to property, (iii) claims of third parties, or (iv) other pecuniary loss, arising out of or related to this disclaimer or the External Site

By entering the External Site, you further acknowledge and agree that the disclaimer of warranties and limitations of liability set out in this disclaimer shall apply regardless of the causes, circumstances or form of action giving rise to the loss, damage, claim or liability, even if such loss, damage, claim or liability is based upon breach of contract (including, without limitation, a claim of fundamental breach or breach of a fundamental term), tort (including, without limitation, negligence), strict liability or any other legal or equitable theory, and even if ITGR and Virtua are advised of the possibility of the loss, damage, claim or liability. The waiver and release specifically includes, without limitation, any and all rights and claims pertaining to the processing of personal data, including but not limited to any rights under any applicable data protection statute(s).

If in any jurisdiction, any part of this disclaimer is held to be unenforceable by a court of competent jurisdiction, such part of this disclaimer shall be restricted or eliminated to the minimum extent and the remaining disclaimer shall otherwise remain in full force and effect.

Please note the information presented is deemed representative at the time of its original release. Changes in historical information may occur due to adjustments in accounting and reporting standards & procedures.

Non-GAAP Information

In addition to disclosing results determined in accordance with GAAP, ITGR may also disclose certain non-GAAP and pro forma non-GAAP results of operations, including certain ratios, operational and miscellaneous data, as well as net income, diluted earnings per share, operating expenses, and operating income that make certain adjustments or exclude certain charges and gains that are outlined in the schedules included in this website. Management believes that this non-GAAP and pro forma non-GAAP information provides investors with additional information to assess ITGR operating performance by making certain adjustments or excluding costs or gains and assists investors in comparing our operating performance to prior periods. Management uses this non-GAAP and pro forma non-GAAP information, along with GAAP information, in evaluating its historical operating performance. ITGR and Virtua also take no responsibility for third party pricing data provided for informational purposes and certain ratio results formulated from the provided third party pricing data.

The non-GAAP information is not prepared in accordance with GAAP and may not be comparable to non-GAAP information used by other companies. The non-GAAP information should not be viewed as a substitute for, or superior to, other data prepared in accordance with GAAP.